Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers

J Am Acad Dermatol. 2013 Sep;69(3):496-8. doi: 10.1016/j.jaad.2013.04.007.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Biomarkers / blood*
  • Cytokines / blood*
  • Female
  • Humans
  • Interferon-gamma / blood
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Re-Epithelialization
  • Retrospective Studies
  • Severity of Illness Index
  • Stevens-Johnson Syndrome / blood
  • Stevens-Johnson Syndrome / drug therapy*
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Cytokines
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interferon-gamma
  • Methylprednisolone